Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Penina Haber

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
The Yale Journal of Biology and Medicine|November 30, 2006
Monitoring vaccine safety during an influenza pandemicJohn Iskander, Penina Haber, Guillermo Herrera
Expert Review of Vaccines|October 4, 2019
Challenges in evaluating post-licensure vaccine safety: observations from the Centers for Disease Control and PreventionPedro L Moro, Penina Haber, Michael M McNeil
Drug Safety|April 25, 2009
Vaccines and Guillain-Barré syndromePenina Haber, James Sejvar, Yann Mikaeloff, et al.
Vaccine|August 16, 2015
Intussusception after monovalent rotavirus vaccine-United States, Vaccine Adverse Event Reporting System (VAERS), 2008-2014Penina Haber, Umesh D Parashar, Michael Haber, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 5, 2004
Postmarketing safety surveillance for typhoid fever vaccines from the Vaccine Adverse Event Reporting System, July 1990 through June 2002Elizabeth M Begier, Dale R Burwen, Penina Haber, et al.
MMWR. Morbidity and Mortality Weekly Report|September 5, 2014
Notes from the field: reports of expired live attenuated influenza vaccine being administered--United States, 2007-2014Penina Haber, Christopher P Schembri, Paige Lewis, et al.
Expert Opinion on Drug Safety|June 9, 2016
Surveillance systems and methods for monitoring the post-marketing safety of influenza vaccines at the Centers for Disease Control and PreventionPedro L Moro, Rongxia Li, Penina Haber, et al.
Vaccine|September 17, 2011
Adverse events after tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine administered to adults 65 years of age and older reported to the Vaccine Adverse Event Reporting System (VAERS), 2005-2010Pedro L Moro, Xin Yue, Paige Lewis, et al.
Human Vaccines & Immunotherapeutics|July 12, 2018
Reports of lower respiratory tract infection following dose 1 of RotaTeq and Rotarix vaccines to the Vaccine Adverse Event Reporting System (VAERS), 2008-2016Penina Haber, Muhammad Amin, Carmen Ng, et al.
Pediatrics|April 20, 2011
Internet-based reporting to the vaccine adverse event reporting system: a more timely and complete way for providers to support vaccine safetyPenina Haber, John Iskander, Kimp Walton, et al.
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
The Yale Journal of Biology and Medicine|November 30, 2006
Monitoring vaccine safety during an influenza pandemicJohn Iskander, Penina Haber, Guillermo Herrera
Expert Review of Vaccines|October 4, 2019
Challenges in evaluating post-licensure vaccine safety: observations from the Centers for Disease Control and PreventionPedro L Moro, Penina Haber, Michael M McNeil
Drug Safety|April 25, 2009
Vaccines and Guillain-Barré syndromePenina Haber, James Sejvar, Yann Mikaeloff, et al.
Vaccine|August 16, 2015
Intussusception after monovalent rotavirus vaccine-United States, Vaccine Adverse Event Reporting System (VAERS), 2008-2014Penina Haber, Umesh D Parashar, Michael Haber, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|March 5, 2004
Postmarketing safety surveillance for typhoid fever vaccines from the Vaccine Adverse Event Reporting System, July 1990 through June 2002Elizabeth M Begier, Dale R Burwen, Penina Haber, et al.
MMWR. Morbidity and Mortality Weekly Report|September 5, 2014
Notes from the field: reports of expired live attenuated influenza vaccine being administered--United States, 2007-2014Penina Haber, Christopher P Schembri, Paige Lewis, et al.
Expert Opinion on Drug Safety|June 9, 2016
Surveillance systems and methods for monitoring the post-marketing safety of influenza vaccines at the Centers for Disease Control and PreventionPedro L Moro, Rongxia Li, Penina Haber, et al.
Vaccine|September 17, 2011
Adverse events after tetanus toxoid, reduced diphtheria toxoid and acellular pertussis (Tdap) vaccine administered to adults 65 years of age and older reported to the Vaccine Adverse Event Reporting System (VAERS), 2005-2010Pedro L Moro, Xin Yue, Paige Lewis, et al.
Human Vaccines & Immunotherapeutics|July 12, 2018
Reports of lower respiratory tract infection following dose 1 of RotaTeq and Rotarix vaccines to the Vaccine Adverse Event Reporting System (VAERS), 2008-2016Penina Haber, Muhammad Amin, Carmen Ng, et al.
Pediatrics|April 20, 2011
Internet-based reporting to the vaccine adverse event reporting system: a more timely and complete way for providers to support vaccine safetyPenina Haber, John Iskander, Kimp Walton, et al.
Pageof 5